Search | IOVS | ARVO Journals

View

Showing 1 – 3 of 3

SORT: Best Match Most Recent Oldest

VIEW: Basic | Expanded

ARVO Annual Meeting Abstract June 2013

Canadian PhIIIb study: ranibizumab combination/monotherapy in visual impairment due to DME: Preliminary Analysis

Thomas Sheidow; Alan Berger; Frederica deTakacsy; Ruihong’ Li; Bonita Rehel; AnneSophie Courseau

Invest. Ophthalmol. Vis. Sci.. 2013; 54(15):4025. doi:

ARVO Annual Meeting Abstract March 2012

A Canadian Registry Of Lucentis Treatment To Collect Effectiveness And Safety Data In Patients With Neovascular Age-related Macular Degeneration Over 36 Months (LENS): Findings From A 12-month Interim Analysis

Sebastien Olivier; Alain Charbonneau; Michel Giunta; Patrick Saurel; Michael Bense; Bonita Rehel; Frederica De Takacsy; Ruihong Li

Invest. Ophthalmol. Vis. Sci.. 2012; 53(14):6520. doi:

ARVO Annual Meeting Abstract March 2012

Spectral-Domain OCT Monitoring in Patients with Choroidal Neovascularization Secondary to Age-related Macular Degeneration, a Lucentis Outcomes Pilot Program (HOLOGRAM): 12-month results

Fareed A. Ali; Eric Tourville; John C. Chen; Peter J. Kertes; Bonita Rehel; Frederica De Takacsy; Ruihong Li

Invest. Ophthalmol. Vis. Sci.. 2012; 53(14):2923. doi:

Advertisement